TUBEROUS SCLEROSIS TREATMENT

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100305150A1
SERIAL NO

12162521

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Rapamycin derivatives for use in the treatment of neurocutaneous disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS PHARMACEUTICALS CORPORATIONONE HEALTH PLAZA EAST HANOVER NJ 07936

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benedetto, John Morristown, US 1 10
Berg, William New City, US 6 26
Elmroth, Ingrid Riehen, CH 1 10
Lane, Heidi Biel-Benken, CH 32 98
Lebwohl, David Madison, US 9 193
Sellers, William Chestnut Hill, US 11 138
Stumm, Michael Riehen, CH 23 566

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation